Articles

Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, Demers E, Morarescu E, Rochefort J, Claessens C.
Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons.
CMAJ. 2007 Jul 31;177(3):252-256.

Dr Rafick-Pierre Sékaly

Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP.
Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction.
Nat Med. 2006 Nov;12(10):1198-1202

Dr Bluma Brenner

Brenner BG, Oliveira M, Doualla-Bell F, Moisi DD, Ntemgwa M, Frankel F, Essex M, Wainberg MA.
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.
AIDS. 2006 Jun 12;20(9):F9-13.

Dr Michel Roger

Valcke HS, Bernard NF, Bruneau J, Alary M, Tsoukas CM, Roger M.
APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians.
AIDS. 2006 Oct 3;20(15):1984-1986.

Dr Francois Coutlée

Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vezina S, Cote P, Macleod J, Voyer H, Forest P, Walmsley S; Canadian Women's HIV study Group; Franco E.
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.
J Clin Microbiol. 2006 Jun;44(6):1998-2006.

Dr Nimâ Machouf

Machouf N, Thomas R, Nguyen VK, Trottier B, Boulassel MR, Wainberg MA, Routy JP.
Effects of drug resistance on viral load in patients failing antiretroviral therapy.
J Med Virol. 2006 May;78(5):608-13.

Dr Michel Roger

Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, Roger M.
Genetic Variants in Nonclassical Major Histocompatibility Complex Class I Human Leukocyte Antigen (HLA)-E and HLA-G Molecules Are Associated with Susceptibility to Heterosexual Acquisition of HIV-1.
J Infect Dis. 2006 193:298-301.

Dr Gaston Godin

Godin G, Cote J, Naccache H, Lambert LD, Trottier S. Related Articles, Links
Prediction of adherence to antiretroviral therapy: a one-year longitudinal study.
AIDS Care. 2005 May;17(4):493-504.

Dr Michel Alary

Vickerman P, Watts C, Delany S, Alary M, Rees H, Heise L. Related Articles, Links
Abstract The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings.
Sex Transm Dis. 2006 Jun;33(6):397-405.

George C, Alary M, Otis J, Demers E, Remis RS, Masse B, Lavoie R, Vincelette J, Parent R, Leclerc R, Turmel B; Omega Study Group, Omega Cohort.
Abstract Nonnegligible increasing temporal trends in unprotected anal intercourse among men who have sexual relations with other men in montreal.
J Acquir Immune Defic Syndr. 2006 Jun;42(2):207-12.

Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men.
Am J Public Health. 2005 Mar;95(3):502-5.

Dr Rafick Pierre Sékaly

Riou C, Dumont AR, Yassine-Diab B, Haddad EK, Sekaly RP. Related Articles, Links
IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells.
Int Immunol. 2006 Jun;18(6):827-35. Epub 2006 Apr 12.

Dr Marina Klein

Boulassel MR, Morales R, Murphy T, Lalonde RG, Klein MB. Related Articles, Links
Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.
J Med Virol. 2006 Sep;78(9):1158-63.

La cohorte Oméga

George C, Alary M, Otis J, Demers E, Remis RS, Masse B, Lavoie R, Vincelette J, Parent R, Leclerc R, Turmel B; Omega Study Group, Omega Cohort.
Nonnegligible increasing temporal trends in unprotected anal intercourse among men who have sexual relations with other men in montreal.
J Acquir Immune Defic Syndr. 2006 Jun;42(2):207-12.

Dr François Coutlée

Plusieurs de nos membres sont régulièrement co-auteurs d'articles publiés dans des revues de hauts calibres scientifiques

Dr Mark A. Wainberg

Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA; Quebec Primary HIV Infection Study Group.
High rates of forward transmission events after acute/early HIV-1 infection.
J Infect Dis. 2007 Apr 1;195(7):951-959

Dr Nicole Bernard

Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Cote P, Longpre D, Routy JP, Falutz J, Tremblay C, Tsoukas CM, Sekaly RP, Bernard NF.
Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
Clin Immunol. 2007 Jul;124(1):57-68

Boulet S, Ndongala ML, Peretz Y, Boisvert MP, Boulassel MR, Tremblay C, Routy JP, Sekaly RP, Bernard NF.
A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.
J Immunol Methods. 2007 Mar 30;320(1-2):18-29

Dr François Coutlée

Gorska-Flipot I, Sawick J, Gaboury LA, Krajinovic M, Labuda D, Brukner I, Rouleau D, Ghattas G, Franco EL, Coutlee F.
Newly-isolated HPV97, related to HPV18 and 45 is frequently detected in HIV-positive men from the montreal area.
Int J Cancer. 2007 Oct 24

Dr Eduardo Franco

Coutlee F, Rouleau D, Ghattas G, Hankins C, Vezina S, Cote P, Macleod J, de Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E.
Confirmatory Real-Time PCR Assay for Human Papillomavirus (HPV) Type 52 Infection in Anogenital Specimens Screened for HPV Infection with the Linear Array HPV Genotyping Test.
J Clin Microbiol. 2007 Nov;45(11):3821-9323

Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group.
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
N Engl J Med. 2007 Oct 18;357(16):1579-1588

Dr Marina Klein

Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB.
Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):463-469.

Dr Michel Alary

Godin G, Tinka Bah A, Sow A, Minani I, Morin D, Alary M.
Correlates of Condom Use among Sex Workers and Their Boyfriends in Three West African Countries.
AIDS Behav. 2007 Aug 21

Diabate S, Alary M, Koffi CK.
Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire.
AIDS. 2007 Aug 20;21(13):1799-1803.

Troesch M, Jalbert E, Canobio S, Boulassel MR, Routy JP, Bernard NF, Bruneau J, Lapointe N, Boucher M, Soudeyns H.
AIDS. 2005 May 20;19(8):775-84.

Makedonas G, Bruneau J, Alary M, Tsoukas CM, Lowndes CM, Lamothe F, Bernard NF. AIDS. 2005 Feb 18;19(3):251-9.

Routy JP, Machouf N, Edwardes MD, Brenner BG, Thomas R, Trottier B, Rouleau D, Tremblay CL, Cote P, Baril JG, Remis RS, Sekaly RP, Wainberg MA.
AIDS. 2004 Nov 19;18(17):2305-12.

Akouamba BS, Viel J, Charest H, Merindol N, Samson J, Lapointe N, Brenner BG, Lalonde R, Harrigan PR, Boucher M, Soudeyns H.
Emerg Infect Dis. 2005 Aug;11(8):1230-4.

Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, Gaseitsiwe S, Oliveira M, Moisi D, Ndwapi N, Moffat H, Essex M, Wainberg MA.
High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C-Infected Batswana Patients Treated with ddI-based regimens.
Antimicrob Agents Chemother. 2006 Oct 2

Autres articles

Validation of a Self-Reported Questionnaire Assessing Adherence to Antiretroviral Medication
GASTON GODIN, Ph.D., CAMILLE GAGNÉ, Ph.D., and HERMINÉ NACCACHE, M.Sc.

Résumé
The aim of this study was to verify the validity of a new self-reported questionnaire designed to assess nonadherence to antiretroviral medication among patients with HIV. (...)
[Vers PubMed Central]

HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation
Marie-Lise Dion, Jean-François Poulin,Rebeka Bordi, Myriam Sylvestre, Rachel Corsini, Nadia Kettaf, Ali Dalloul,Mohamed-Rachid Boulassel, Patrice Debré, Jean-Pierre Routy, Zvi Grossman, Rafick-Pierre Sékaly and Rém Cheynier

Résumé
T cell receptor excision circles (TRECs), molecular markers of distinct T cell receptor rearrangements occurring at different stages of thymocyte development, was measured in peripheral blood-mononuclear cells (PBMCs). (...)
[Vers PubMed Central]

Genetic Basis of Hypersusceptibility to Protease Inhibitors and Low Replicative Capacity of Human Immunodeficiency Virus Type 1 Strains in Primary Infection Andrew J. Leigh Brown, Simon D. W. Frost,2 Benjamin Good, Eric S. Daar, Viviana Simon, Martin Markowitz, Ann C. Collier, Elizabeth Connick, Brian Conway, Joseph B. Margolick,8 Jean-Pierre Routy, Jacques Corbeil, Nicholas S. Hellmann, Douglas D. Richman and Susan J.

Résumé
The initial virus strains from as many as 12% of individuals with primary human immunodeficiency virus (HIV) infection have a 50% inhibitory concentration <0.4-fold that of HIV type 1NL4-3 (HIV-1NL4-3) to ritonavir (hypersusceptibility [HS]). (...)
[Vers PubMed Central]

Circulating Levels of IL-7 but not IL-15, IGF-1, and TGF-β Are Elevated During Primary HIV-1 Infection
M.R. Boulassel, M. Young, and J.P. Routy, R.P. Sekaly, C. Tremblay, and D. Rouleau

Résumé
Recognition of the potential role of certain cytokines and growth factors such as interleukin-7 (IL-7), IL-15, and insulin-like growth factor-1 (IGF1) in CD4 cell homeostasis has paved the way for investigations into their possible usefulness in the treatment of human immunodeficiency virus (HIV) infection.(range, 3.9–6.5). Patients were studied at two time points: at study entry (T 0) and 12 months later (T1; range, 10–14). Therapy was initiated on average 30 ± 37 days (range, 1–120) after baseline sampling (T 0). (...)
[Vers PubMed Central]

Autres sections

Articles
Études
Rapports